1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Pigment Glaucoma Global Clinical Trials Review, H2, 2015

Pigment Glaucoma Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Pigment Glaucoma Global Clinical Trials Review, H2, 2015" provides an overview of Pigment Glaucoma clinical trials scenario. This report provides top line data relating to the clinical trials on Pigment Glaucoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Pigment Glaucoma Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Pigment Glaucoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Clinical Trials by G7 Countries: Proportion of Pigment Glaucoma to Ophthalmology Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Pigment Glaucoma to Ophthalmology Clinical Trials 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Unaccomplished Trials of Pigment Glaucoma 21
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Top Companies Participating in Pigment Glaucoma Therapeutics Clinical Trials 25
Prominent Drugs 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Novartis AG 27
Clinical Trial Overview of Novartis AG 27
Valeant Pharmaceuticals International, Inc. 28
Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 28
Pfizer Inc. 29
Clinical Trial Overview of Pfizer Inc. 29
Merck and Co., Inc. 30
Clinical Trial Overview of Merck and Co., Inc. 30
Kowa Company, Ltd. 31
Clinical Trial Overview of Kowa Company, Ltd. 31
Genovate Biotechnology Co., LTD. 32
Clinical Trial Overview of Genovate Biotechnology Co., LTD. 32
Aurolab 33
Clinical Trial Overview of Aurolab 33
Allergan Plc 34
Clinical Trial Overview of Allergan Plc 34
Alcon, Inc. 35
Clinical Trial Overview of Alcon, Inc. 35
Clinical Trial Overview of Top Institutes / Government 36
Cardiff University 36
Clinical Trial Overview of Cardiff University 36
Johannes Gutenberg University Mainz 37
Clinical Trial Overview of Johannes Gutenberg University Mainz 37
Medical University of Vienna 38
Clinical Trial Overview of Medical University of Vienna 38
Yale University 39
Clinical Trial Overview of Yale University 39
Five Key Clinical Profiles 40
Appendix 61
Abbreviations 61
Definitions 61
Research Methodology 62
Secondary Research 62
About GlobalData 63
Contact Us 63
Disclaimer 63
Source 64

List of Tables
Pigment Glaucoma Therapeutics, Global, Clinical Trials by Region, 2015* 7
Pigment Glaucoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Pigment Glaucoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Pigment Glaucoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Pigment Glaucoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Pigment Glaucoma Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Proportion of Pigment Glaucoma to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 13
Pigment Glaucoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Pigment Glaucoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Proportion of Pigment Glaucoma to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 16
Pigment Glaucoma Therapeutics, Global, Clinical Trials by Phase, 2015* 17
Pigment Glaucoma Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 18
Pigment Glaucoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 19
Pigment Glaucoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 20
Pigment Glaucoma Therapeutics, Global, Terminated Clinical Trials, 2015* 21
Pigment Glaucoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22
Pigment Glaucoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 23
Pigment Glaucoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24
Pigment Glaucoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25
Pigment Glaucoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26
Pigment Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 27
Pigment Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015* 28
Pigment Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 29
Pigment Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck and Co., Inc., 2015* 30
Pigment Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kowa Company, Ltd., 2015* 31
Pigment Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Genovate Biotechnology Co., LTD., 2015* 32
Pigment Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Aurolab, 2015* 33
Pigment Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan Plc, 2015* 34
Pigment Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Alcon, Inc., 2015* 35
Pigment Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Cardiff University, 2015* 36
Pigment Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Johannes Gutenberg University Mainz, 2015* 37
Pigment Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015* 38
Pigment Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2015* 39

List of Figures
Pigment Glaucoma Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Pigment Glaucoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Pigment Glaucoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Pigment Glaucoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Pigment Glaucoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Proportion of Pigment Glaucoma to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 13
Pigment Glaucoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Pigment Glaucoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Proportion of Pigment Glaucoma to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 16
Pigment Glaucoma Therapeutics, Global, Clinical Trials by Phase (%), 2015* 17
Pigment Glaucoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 18
Pigment Glaucoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 19
Pigment Glaucoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22
Pigment Glaucoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 23
Pigment Glaucoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24
Pigment Glaucoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 25
Pigment Glaucoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 26
GlobalData Methodology 62

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.